Novel potent and selective mineralocorticoid receptor antagonists were identified, utilizing heterocyclic amide replacements in the oxazolidinedione series. Structure–activity relationship (SAR) efforts focused on improving lipophilic ligand efficiency (LLE) while maintaining nuclear hormone receptor selectivity and reasonable pharmacokinetic profiles.
利用
恶唑烷二酮系列中的杂环酰胺替代品,鉴定出新型有效且选择性的盐皮质激素受体拮抗剂。构效关系(
SAR)的工作重点是提高亲脂性
配体效率(LLE),同时保持核激素受体选择性和合理的药代动力学特征。